Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis.
Frontiers in pharmacology（2023）
摘要
[This corrects the article DOI: 10.3389/fphar.2022.838449.].
更多查看译文
关键词
idiopathic pulmonary fibrosis,pde4b inhibitor,corrigendum,clinical drug candidate
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要